AstraZeneca considers spinning off drug research unit

02/12/2008 | Times (London) (subscription required), The

AstraZeneca said it is considering a sale of its Sweden-based gastrointestinal drug research unit to venture capitalists. The company did not comment on the news report but a spokeswoman said the firm continues to "explore a range of options on an ongoing basis."

View Full Article in:

Times (London) (subscription required), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ